⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
VNRX News
VolitionRX Limited Common Stock
Form 8-K
sec.gov
VNRX
VolitionRx Announces Acceptance of Compliance Plan by NYSE American
prnewswire.com
VNRX
Volition Launches rNuQ™ Webshop Broadening Product Range
prnewswire.com
VNRX
Form 8-K
sec.gov
VNRX
Form 8-K
sec.gov
VNRX
Form 8-K
sec.gov
VNRX
VolitionRx Secures EUR 2.0 Million of Non-Dilutive Funding from Regional Government Agencies in Belgium
prnewswire.com
VNRX
Volition Announces Mayo Clinic Study Demonstrates Nu.Q® Concentrations are Elevated in Trauma Patients
prnewswire.com
VNRX
Volition Announces Abstract Demonstrating Risk Stratification in Lung Cancer Presented at the European Lung Cancer Conference
prnewswire.com
VNRX
Volition Announces Detection of Over 95% of Early-Stage Cancers
prnewswire.com
VNRX